Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Filer

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Nature|June 6, 2020
Notch signalling drives synovial fibroblast identity and arthritis pathologyKevin Wei, Ilya Korsunsky, Jennifer L Marshall, et al.
Arthritis and Rheumatism|February 2, 2012
Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cellsMohammad M Ahasan, Rowan Hardy, Christopher Jones, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markersDarren Plant, Edward Flynn, Hamdi Mbarek, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?Susan R Aungier, Alison J Cartwright, Anja Schwenzer, et al.
RMD Open|January 20, 2025
EULAR standardised training model for ultrasound-guided, minimally invasive synovial tissue biopsy procedures in large and small jointsIngrid Möller, Raquel Largo, David A Bong, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathologySaba Nayar, Joana Campos, Charlotte G Smith, et al.
RMD Open|April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritisLeher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.
BMJ Open|March 3, 2026
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocolBenjamin A Fisher, Anna Rowe, Chris Hodson, et al.
BMJ Open|April 9, 2025
Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine studyFiona Rayner, Shaun Hiu, Andrew Melville, et al.
RMD Open|November 30, 2018
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across EuropeSøren Andreas Just, Frances Humby, Hanne Lindegaard, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Nature|June 6, 2020
Notch signalling drives synovial fibroblast identity and arthritis pathologyKevin Wei, Ilya Korsunsky, Jennifer L Marshall, et al.
Arthritis and Rheumatism|February 2, 2012
Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cellsMohammad M Ahasan, Rowan Hardy, Christopher Jones, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markersDarren Plant, Edward Flynn, Hamdi Mbarek, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?Susan R Aungier, Alison J Cartwright, Anja Schwenzer, et al.
RMD Open|January 20, 2025
EULAR standardised training model for ultrasound-guided, minimally invasive synovial tissue biopsy procedures in large and small jointsIngrid Möller, Raquel Largo, David A Bong, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathologySaba Nayar, Joana Campos, Charlotte G Smith, et al.
RMD Open|April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritisLeher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.
BMJ Open|March 3, 2026
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocolBenjamin A Fisher, Anna Rowe, Chris Hodson, et al.
BMJ Open|April 9, 2025
Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine studyFiona Rayner, Shaun Hiu, Andrew Melville, et al.
RMD Open|November 30, 2018
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across EuropeSøren Andreas Just, Frances Humby, Hanne Lindegaard, et al.
Pageof 17